Krebs Biochemicals & Industries Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 163.034 million compared to INR 148.534 million a year ago. Net loss was INR 69.866 million compared to INR 61.572 million a year ago. Basic loss per share from continuing operations was INR 3.47 compared to INR 3.78 a year ago. For the full year, total revenue was INR 543.217 million compared to INR 337.773 million a year ago. Net loss was INR 283.586 million compared to INR 288.719 million a year ago. Basic loss per share from continuing operations was INR 14.53 compared to INR 17.9 a year ago.